Eloxx Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2001 | — | $-206.7K | — |
| FY2002 | — | $4.8M | — |
| FY2003 | — | $2.9M | — |
| FY2004 | — | $4.7M | — |
| FY2005 | — | $5.6M | — |
| FY2006 | — | $3.0M | — |
| FY2007 | — | $2.7M | — |
| FY2008 | — | $9.8M | — |
| FY2009 | — | $5.7M | $380.6K |
| FY2010 | — | $8.0M | $8.0M |
| FY2011 | — | $4.5M | $3.6M |
| FY2012 | — | $3.5M | $2.0M |
| FY2013 | — | $3.8M | $1.6M |
| FY2014 | — | $27.5M | $6.1M |
| FY2015 | — | $12.2M | $3.3M |
| FY2016 | — | $4.6M | $810.8K |
| FY2017 | — | $871.2K | $33.2K |
| FY2018 | — | $42.9M | $48.6M |
| FY2019 | $10.5M | $36.2M | $22.5M |
| FY2020 | $6.4M | $10.2M | $24.7M |
| FY2021 | $12.0M | $22.4M | $42.3M |
| FY2022 | $8.6M | $-10.7M | $19.2M |
| FY2023 | $1.6M | $-22.6M | $1.1M |
| FY2024 | $0 | $-24.3M | $111.0K |
| FY2025 | $0 | $-11.9M | $4.8M |